Kwality Pharmaceuticals Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 654,000 (47%) | — | ₹294 Cr |
| Retail | — | 654,000 (47%) | — | ₹294 Cr |
| Market Maker | — | 72,000 (5%) | — | ₹3 Cr |
| Σ Total | — | 1,380,000 (100%) | — | ₹6,210 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 3,000 | ₹135,000 |
| Retail (Max) | 13 | 39,000 | ₹1,755,000 |
| S-HNI (Min) | 14 | 42,000 | ₹1,890,000 |
| B-HNI (Min) | 67 | 201,000 | ₹9,045,000 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Modernisation of the Laboratory – 0.43
- 2 General Corporate Purpose – 0.20
- 3 Offer Expenses – 0.18
Company Overview
Incorporated in 1983, Kwality Pharmaceuticals Ltd (KPL) is engaged in the business of manufacturing of broad range of finished pharmaceutical formulations in a dosage form. Information in this paragraph is copied from chittorgarh.com.KPL is one of the leading manufacturer & exporters of pharmaceutical formulations in Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectable. The company has registered all its products in different Countries of Europe, Africa, Asia & CIS Countries.
According to the Company, it has the most modern & sophisticated plant, equipment's, technique and manpower and is working with new SCHEDULE M and W.H.O. norms and certified with GMP and WHO certificate.